Literature DB >> 1101675

New observations on the effects of atropine on the sinoatrial and atrioventricular nodes in man.

G Das, F N Talmers, A M Weissler.   

Abstract

Previous observations of slowing of the heart rate after administration of atropine in doses smaller than 0.4 mg and recent reports of development of rhythm disorders in patients with acute myocardial infarction given atropine prompted us to evaluate systematically the effects of various doses of atropine (0.1 to 0.8 mg) on the response of the sinoatrial (S-A) and atrioventricular (A-V) nodes in healthy volunteers. The response of the S-A node to atropine was characteristically bimodal, slowing at smaller doses and accelerating at larger doses. In contrast, the A-V node showed acceleration of conduction in response to all doses of atropine used. A hypothesis based on current understanding of the electrophysiologic parameters governing impulse formation and impulse conduction is advanced to explain the apparent paradox in the S-A and A-V nodal responses to small doses of atropine. The results suggest the need for caution and continuous rhythm monitoring when giving atropine to patients with acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1101675     DOI: 10.1016/0002-9149(75)90476-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Editorial: First aid in acute myocardial infarction.

Authors: 
Journal:  Br Med J       Date:  1976-02-14

2.  The use of isometric exercise as a means of evaluating the parasympathetic contribution to the tachycardia induced by dynamic exercise in normal man.

Authors:  L Gallo; B C Maciel; J A Marin-Neto; L E Martins; E C Lima-Filho; J C Manço
Journal:  Pflugers Arch       Date:  1988-07       Impact factor: 3.657

3.  Relationships between heart rate and PR interval during physiological and pharmacological interventions.

Authors:  S G Carruthers; B McCall; B A Cordell; R Wu
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

4.  Tachy-bradycardia syndrome related to lithium therapy.

Authors:  K C Wong
Journal:  Can Med Assoc J       Date:  1981-05-15       Impact factor: 8.262

5.  Atropine...bradycardia...asystole...? Arrest: case report.

Authors:  I R Weinstein
Journal:  Anesth Prog       Date:  1982 Jul-Aug

6.  Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats.

Authors:  Susan K Wood; Robert E Verhoeven; Aaron Z Savit; Kenner C Rice; Peter S Fischbach; James H Woods
Journal:  Neuropsychopharmacology       Date:  2006-05-03       Impact factor: 7.853

7.  Should the routine use of atropine before succinylcholine in children be reconsidered?

Authors:  G McAuliffe; B Bissonnette; C Boutin
Journal:  Can J Anaesth       Date:  1995-08       Impact factor: 5.063

8.  The risk of adverse events associated with atropine administration during dobutamine stress echocardiography in cardiac transplant patients: a 28-year single-center experience.

Authors:  James Wang Ji; Siqin Ye; Jennifer Haythe; P Christian Schulze; Daichi Shimbo
Journal:  J Card Fail       Date:  2013-10-09       Impact factor: 5.712

9.  Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors.

Authors:  A Wellstein; H F Pitschner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

10.  The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.

Authors:  J Camm; D Ward; R A Spurrell
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.